Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 180 publications
Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma.
Journal: Transplantation and cellular therapy
Published: March 11, 2026
The clinical applications of next-generation sequencing and ctDNA/cfDNA in lymphoma.
Journal: Clinical advances in hematology & oncology : H&O
Published: February 20, 2026
Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: February 02, 2026
Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: February 02, 2026
Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2.
Journal: Journal of hematology & oncology
Published: December 30, 2025
CD19 CAR T-Cell Therapy in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Journal: American journal of hematology
Published: November 05, 2025
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma.
Journal: Blood
Published: September 03, 2025
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.
Journal: Blood
Published: September 03, 2025
CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 05, 2025
Last Updated: 09/26/2026